Medical device for treating diabetes

US11420051B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11420051-B2
Application numberUS-201815982486-A
CountryUS
Kind codeB2
Filing dateMay 17, 2018
Priority dateMay 17, 2018
Publication dateAug 23, 2022
Grant dateAug 23, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical device containing a sensor, a motor, one or more plates, and a control unit, for treating diabetes. The medical device vibrates the pancreas thereby improving blood and secretory hormone circulation and enhancing the production of insulin.

First claim

Opening claim text (preview).

The invention claimed is: 1. A medical device, comprising: a glucose sensor; a single vibration motor, wherein the vibration motor is an ultrasonic transducer configured to vibrate at 40-60 kHz, wherein the plate has a single inner surface and a single outer surface; a single plate, wherein the plate is connected to the motor through a rod having first and second circular faces, wherein the first circular face of the rod is in direct contact with the vibration motor and the second circular face is in direct contact with the plate, and the plate and motor are implantable in a patient; a control unit in communication with the motor and the glucose sensor, wherein the plate is configured to conform to a surface of a pancreas of the patient and the entire inner surface of the plate has a microstructured surface that is configured to be in continuous contact with the surface of the pancreas of the patient, wherein the plate has a continuous curve structure configured to conform with a shape of the pancreas so that an apex of the curve structure is configured to cover a head portion of the pancreas and a chord of the curve corresponds with a tail portion of the pancreas, wherein the vibration motor is connected to the plate at the apex of the curve structure and the plate has a longitudinal axis configured to be parallel to a longitudinal axis of the pancreas; wherein the plate is configured to be between the vibration motor and the surface of the pancreas and the entire inner surface of the plate is configured to be in contact with the surface of the pancreas, wherein the microstructured surface has a pattern of repeating microstructure protrusions having an average height of 0.02-2 mm and an average distance between each microstructure protrusion and an adjacent microstructure protrusion is in a range of 5-100 μm, and wherein the plate has a length in a range of 15-50 mm, a width in a range of 1-25 mm and a thickness in a range of 0.1-2 mm. 2. The medical device of claim 1 , wherein the plate is flexible. 3. The medical device of claim 1 , wherein the plate comprises silicone. 4. The medical device of claim 1 , wherein the control unit comprises: a display; at least one battery; and a central processing unit electrically connected to the vibration motor and the glucose sensor. 5. The medical device of claim 1 , wherein the control unit is configured to actuate and deactuate the vibration motor based on a blood glucose level feedback from the glucose sensor, thereby keeping a blood glucose level within a range of 70-140 mg/dl. 6. The medical device of claim 1 , wherein the microstructure protrusions are made of or coated with one or more selected from the group consisting of alginate, hyaluronic acid and collagen. 7. The medical device of claim 1 , wherein the chord of the curve is in a range of from 0.2-3 mm.

Assignees

Inventors

Classifications

  • Other apparatus for introducing media into the body (for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30); Percutany, i.e. introducing medicines into the body by diffusion through the skin (salt baths A61H33/04) · CPC title

  • Implanted circuitry · CPC title

  • stomach · CPC title

  • Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow · CPC title

  • Measuring electrical impedance or conductance of a portion of the body · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11420051B2 cover?
A medical device containing a sensor, a motor, one or more plates, and a control unit, for treating diabetes. The medical device vibrates the pancreas thereby improving blood and secretory hormone circulation and enhancing the production of insulin.
Who is the assignee on this patent?
Univ Imam Abdulrahman Bin Faisal
What technology area does this patent fall under?
Primary CPC classification A61N7/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).